Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06724978 · ClinicalTrials.gov registry record · Phase 1
A Study of S-740792 in Healthy Adult Study Participants
A Phase 1 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 1
- Development phase
- 99
- Enrollment target
NCT06724978 is a Phase 1 study that has completed, run by Shionogi. The registered enrollment target is 99 participants.
The verdict
NCT06724978, a Phase 1 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 99 participants
- Enrollment target
Study Summary
This is a 3-part study of S-740792 in healthy adult participants. Part 1 (single-ascending-dose and food effect) will investigate the safety, tolerability, and pharmacokinetics (PK) of S-740792. Part 2 (multiple-ascending-dose and drug-drug interaction) will investigate the safety, tolerability, and PK of S-740792, in addition, the effect of multiple doses of S-740792 on the PK of midazolam. Part 3 will investigate the relative bioavailability of S-740792 tablet compared to S-740792 suspension and the food effect on the PK of the S-740792 tablet.
Interventions
- DRUG Placebo
- DRUG Midazolam
- DRUG S-740792 Suspension
- DRUG S-740792 Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2024-11-21 |
| Est. Completion | 2025-09-24 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06724978
The ClinicalTrials.gov registry entry for NCT06724978 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT06724978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06724978 about?
NCT06724978 is a clinical study titled "A Study of S-740792 in Healthy Adult Study Participants". This is a 3-part study of S-740792 in healthy adult participants. Part 1 (single-ascending-dose and food effect) will investigate the safety, tolerability, and pharmacokinetics (PK) of S-740792. Part 2 (multiple-ascending-dose and drug-drug interaction) will investigate the safety, tolerability, and...
What is the current status of trial NCT06724978?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 99 participants. The study started on 2024-11-21. Estimated completion is 2025-09-24.
What interventions are being tested in trial NCT06724978?
The interventions under investigation include: Placebo (DRUG), Midazolam (DRUG), S-740792 Suspension (DRUG), S-740792 Tablet (DRUG).
Who is sponsoring clinical trial NCT06724978?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.